Should protracted withdrawal from drugs be included in DSM-IV?

American Journal of Psychiatry

Volumn 150, Issue 5, 1993, Pages 695-704

  Satel, Sally L ^a   Kosten, Thomas R ^b   Schuckit, Marc A ^b   Fischman, Marian W ^b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BRAIN RECEPTOR; CENTRAL STIMULANT AGENT; COCAINE; DIAMORPHINE; MORPHINE; OPIATE DERIVATIVE;

ALCOHOL ABUSE; ALCOHOL WITHDRAWAL; ANXIETY; CONDITIONING; DEPRESSION; DRUG ABUSE; DRUG WITHDRAWAL; DYSPHORIA; HUMAN; MOOD; NEUROCHEMISTRY; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYMPTOM; SYNDROME DELINEATION; WITHDRAWAL SYNDROME;

CENTRAL NERVOUS SYSTEM STIMULANTS; ETHANOL; HUMAN; NARCOTICS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SUBSTANCE WITHDRAWAL SYNDROME; SUPPORT, U.S. GOV'T, P.H.S.; TERMINOLOGY;

EID: 0027156871     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.150.5.695     Document Type: Article

References (109)

1. Himmelsbach CK: Clinical studies of drug addiction: physical dependence, withdrawal and recovery. Arch Intern Med 1942; 69:766-772
2. Kissin B, Schenker V, Schenker A: The acute effects of ethyl alcohol and chlorpromazine on certain physiological functions in alcoholics. Q J Stud Alcohol 1959; 20:480-492
3. Martin WR: The pathophysiology of narcotic addiction: possible roles of protracted abstinence in relapse, in Drug Abuse: Proceedings of the International Conference on Drug Abuse, Ann Arbor, Mich, 1970. Edited by Zarafonetis CDJ. Philadelphia, Lea & Febiger, 1972
4. Meyer RE: Prospects for a rational pharmacotherapy of alcoholism. J Clin Psychiatry 1989; 50:403-412
5. Kissin B: Biological investigation in alcoholics. J Stud Alcohol Suppl 1979; 8:146-181
6. O'Brien CP, Testa T, O'Brien TJ, Brady JP, Wells P: Conditioned narcotic withdrawal in humans. Science 1977; 95:1000-1002
7. Haertzen CA, Ross FF: Strength of drug habits: for heroin, morphine, methadone, alcohol, barbiturates, pentobarbital, benzedrine, cocaine and marijuana. Drug Alcohol Depend 1980; 5:439-455
8. Marlatt GA: Relapse prevention: theoretical rationale and overview of the model, in Relapse Prevention. Edited by Marlatt GA, Gordon JG. New York, Guilford Press, 1985
9. Jaffe JH: Drug addiction and drug abuse, in Goodman and Gilman's Pharmacologic Basis of Therapeutics, 8th ed. Edited by Gilman AG, Rall TW, Nies AS, Taylor P. New York, Pergamon Press, 1990
10. Redmond DE, Krystal JH: Multiple mechanisms of withdrawal from opioid drugs. Ann Rev Neurosci 1984; 7:443-478
11. Volkow ND, Hitzemann R, Fowler JS, Wolf AP: reply to WW Weddington: Issues regarding short-term abstinence in outpatient cocaine addicts (letter). Am J Psychiatry 1991; 148:1759-1760
12. Schuckit MA: Drug and Alcohol Abuse: A Clinical Guide to Diagnosis and Treatment, 3rd ed. New York, Plenum Medical, 1989, p 16
13. Schuckit MA: Anxiety disorders and substance abuse, in American Psychiatric Press Review of Psychiatry, vol 11. Edited by Tasman A, Riba MB. Washington, DC, American Psychiatric Press, 1992
14. Brown SA, Schuckit MA: Changes in depression among abstinent alcoholics. J Stud Alcohol 1988; 49-412-417
15. Brown SA, Irwin M, Schuckit MA: Changes in anxiety among abstinent male alcoholics. J Stud Alcohol 1991; 52:55-61
16. Wellman M: The late withdrawal symptoms of alcoholic addiction. Can Med Assoc J 1954; 70:526-529
17. Whitfield KL: Nondrug detoxification, in Phenomenology and Treatment of Alcoholism. Edited by Fann WE, Karacan I, Pokorny AD, Williams AD, Williams RL. New York, Spectrum, 1980
18. Worden M, Rossellini G: The dry drunk syndrome: a toximolecular interpretation. J Orthomolecular Psychiatry 1980; 9:41-47
19. Segal BM, Kushnarev VM, Urakov IG, Misionzhnik EU: Alcoholism and disruption of the activity of deep cerebral structures: clinical-laboratory research. Q J Stud Alcohol 1970; 31:587-601
20. Katta BB: Nifedipine for protracted withdrawal syndrome (letter). Can J Psychiatry 1991; 36:155
21. Begleiter H, Porjesz B: Persistence of a "subacute withdrawal syndrome" following chronic ethanol intake. Drug Alcohol Depend 1979; 4:353-357
22. Ailing C, Balldin J, Bokstrom K, Gottfries CG, Karlsson I, Langstrom G: Studies on duration of a late recovery period after chronic abuse of ethanol: a cross-sectional study of biochemical and psychiatric indicators. Acta Psychiatr Scand 1982; 66:384-397
23. Woodruff RA, Guze SB, Clayton PJ, Carr D: Alcoholism and depression. Arch Gen Psychiatry 1973; 28:97-100
24. Keeler MH, Taylor CI, Miller WC: Are all recently detoxified alcoholics depressed? Am J Psychiatry 1979; 136:586-588
25. Hesselbrock MN, Meyer RE, Keener JJ: Psychopathology in hospitalized alcoholics. Arch Gen Psychiatry 1985; 42:1050-1055
26. Schuckit MA: Alcoholism and other psychiatric disorders. Hosp Community Psychiatry 1983; 34:1022-1027
27. Smail P, Stockwell T, Canter S, Hodgson R: Alcohol dependence and phobic anxiety states, II: a retrospective study. Br J Psychiatry 1984; 144:53-57
28. De Soto CB, O'Donnell WE, Alfred LJ, Lopes CE: Symptomatology in alcoholics at various stages of abstinence. Alcohol Clin Exp Res 1985; 9:505-512
29. Victor M: The role of hypermagnesemia and respiratory alkalosis in the genesis of alcohol withdrawal symptoms. Ann NY Acad Sci 1973; 215:235-248
30. Kalant H: Alcohol withdrawal syndromes in human and animal models, in Alcohol Intoxication and Withdrawal, vol III: 6 Studies in Alcohol Dependence. New York, Plenum, 1977
31. Roelofs SM: Hyperventilation, anxiety, craving for alcohol: a subacute alcohol withdrawal syndrome. Alcohol 1985; 2:501-505
32. Roelofs SM, Dikkenberg GM: Hyperventilation and anxiety: alcohol withdrawal symptoms decreasing with prolonged abstinence. Alcohol 1987; 4:215-220
33. Coger RW, Dymond AM, Serafetinides EA, Lowenstam I, Pearson D: Alcoholism: averaged visual evoked response amplitude-intensity, slope and symmetry in withdrawal. Biol Psychiatry 1976; 11:435-143
34. Wagman AMI, Allen RP, Funderburk F, Upright D: EEG measures of functional tolerance to alcohol. Biol Psychiatry 1978; 13:719-728
35. Pfefferbaum A, Horvath TB, Roth WT, Kopell BS: Event-related potential changes in chronic alcoholics. Electroencephalogr Clin Neurophysiol 1979; 47:637-647
36. Adamson J, Burdick JA: Sleep of dry alcoholics. Arch Gen Psychiatry 1973; 28:146-149
37. Rundell OH, Lester BK, Griffiths WJ, Williams HL: Alcohol and sleep in young adults. Psychopharmacologia 1972; 26:201-218
38. Wagman AM, Allen RP: Effects of alcohol ingestion and abstinence on slow-wave sleep of alcoholics. Adv Exp Med Biol 1975; 59:453-466
39. Rundell OH, Williams HL, Lester BK: Sleep in alcoholic patients: longitudinal findings. Adv Exp Med Biol 1977; 85B:389-402
40. Snyder S, Karacan I: Sleep patterns of sober chronic alcoholics, in New Research Abstracts, 135th Annual Meeting of the American Psychiatric Association. Washington, DC, APA, 1982
41. Gillin JC, Smith TL, Irwin M, Kripke DF, Schuckit M: EEG sleep studies in pure primary alcoholism during subacute withdrawal: relationships to normal controls, age and other clinical variables. Biol Psychiatry 1990; 27:477-488
42. Loosen PT, Prange AJ, Wilson IC: TRH (protirelin) in depressed alcoholic men: behavioral changes and endocrine responses. Arch Gen Psychiatry 1979; 36:540-547
43. Khan H, Ciraulo DA, Nelson WH, Becker JT, Nies A, Jaffe JH: Dexamethasone supression test in recently detoxified alcoholics: clinical implications. J Clin Psychopharmacol 1984; 4:94-97
44. Carroll BJ: Biologic markers and treatment response. J Clin Psychiatry 1983; 44:30-36
45. Adner N, Nygren A: Insulin sensitivity in alcoholics in a withdrawal state. J Intern Med 1990; 228:59-64
46. Lovallo W, Parsons OA, Holloway FA: Autonomic arousal in normal, alcoholic and brain-damaged subjects as measured by plethysmograph response to cold presser stimulation. Psychophysiology 1973; 10:166-176
47. Cook S, Besson JA, Boyd J, Skinner ER: Changes in blood lipids and lipoproteins in chronic alcoholics during alcohol withdrawal. Biochem Soc Trans 1990; 18:679-680
48. Hore B: Craving for alcohol. Br J Addict 1974; 31:137-140
49. Gorelick DA, Wilkins JN: Social aspects of human alcohol withdrawal, in Recent Developments in Alcoholism, vol 4. Edited by Galanter M. New York, Plenum, 1986
50. Wise RA: The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol 1988; 97:118-132
51. Dole VP: Narcotic addiction, physical dependence and relapse. N Engl J Med 1972; 286:988-992
52. Dole VP: Implications of methadone maintenance for theories of narcotic addiction. JAMA 1988; 260:3025-3029
53. Meyer RE, Mirin SM, Altman JL, McNamee HB: A behavioral paradigm for the evaluation of narcotic antagonists. Arch Gen Psychiatry 1976; 33:371-377
54. Sideroff SI, Charuvastra VC, Jarvik ME, Ouren J: Craving in heroin addicts maintained on opiate antagonist naltrexone. Am J Drug Alcohol Abuse 1978; 5:415-423
55. Bozarth MA, Wise RA: Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science 1984; 224:516-517
56. Goeders NE, Smith JE: Conical dopaminergic involvement in cocaine reinforcement. Science 1983; 221:773-775
57. Olds ME, Williams KN: Self-administration of D-ala2-metenkephalinamide at hypothalamic self-stimulation sites. Brain Res 1980; 194:155-170
58. Kolb L: The struggle for cure and the conscious reasons for relapse. J Nerv Ment Dis 1927; 66:22-43
59. Himmelsbach CK: Clinical studies of morphine addictions: Nathan B Eddy Memorial Award Lecture, in Proceedings of the 49th Annual Meeting of the Committee on the Problems of Drug Dependence: NIDA Research Monograph 81. Edited by Harris LS. Rockville Md, National Institute on Drug Abuse, 1988
60. Martin WR, Jasinski DR: Physiological parameters of morphine in man - tolerance, early abstinence and protracted abstinence. J Psychiatr Res 1969; 7:9-17
61. Eisenman AJ, Sloan JW, Martin WR, Jasinski DR, Brooks JW: Catecholamine and 17-hydroxycorticosteroid excretion during a cycle of morphine dependence in man. J Psychiatr Res 1969; 7:19-28
62. Mendelson JH, Mello NK: Plasma testosterone levels during chronic heroin use and protracted withdrawal. Clin Pharm Ther 1975; 17:529-533
63. Martin SD, Yeragani VK, Lodhi R, Galloway MP: Clinical ratings and plasma HVA during cocaine abstinence. Biol Psychiatry 1989; 26:356-362
64. Khazan N, Colasanti B: EEG correlates of morphine challenge in post-addict rats. Psychopharmacologia (Berl) 1971; 22:56-63
65. Goldberg SR, Schuster CR: Nalorphine: increases sensitivity of monkeys formerly dependent on morphine. Science 1969; 166:1548-1549
66. Brase DA, Iwamoto ET, Loh HH, Way EL: Reinitiation of sensitivity to naloxone by a single narcotic injection in postaddicted mice. J Pharmacol Exp Ther 1976; 197:317-325
67. Lal H, Puri SK: Morphine withdrawal aggression: role of dopaminergic stimulation. Drug Addiction 1972; 1:301-310
68. Gianutsos G, Hynes MD, Puri SK, Drawbaugh RB, Lal H: Effect of apomorphine and nigrostriatal lesions on aggression and striatal dopamine turnover during morphine withdrawal: evidence for dopaminergic supersensitivity in protracted abstinence. Psychopharmacologia (Berl) 1974; 34:37-44
69. Click S, Cox RD: Changes in sensitivity to operant effects of dopaminergic and cholinergic agents following morphine withdrawal in rats. Eur J Pharmacol 1977; 42:303-306
70. Carlson KR, Cooper DO: Morphine dependence and protracted abstinence: regional alterations in CNS radioligand binding. Pharmacol Biochem Behav 1985; 23:1059-1064
71. Wilder A, Pescor FT: Classical conditioning of a morphine abstinence phenomenon, reinforcement of opioid-drinking behavior and "relapse" in morphine-addicted rats. Psychopharmacologia (Berl) 1967; 10:255-284
72. Wikler A, Pescor FT, Miller D, Norrell H: Persistent potency of a secondary (conditioned) reinforcer following withdrawal of morphine from physically dependent rats. Psychopharmacologia (Berl) 1971; 20:103-117
73. Lynch JJ, Fertiziger AP, Teitelbaum HA, Cullen JW, Gantt WH: Pavlovian conditioning of drug reactions: some implications for the problems of drug addiction. Cond Reflex 1973; 8:211-223
74. Eikelboom R, Stewart J: Conditioned temperature effects using morphine as the unconditioned stimulus. Psychopharmacology 1981; 61:31-38
75. Wikler A: Dynamics of drug dependence. Arch Gen Psychiatry 1973; 28:611-616
76. Teasdale JD: Conditioned abstinence in narcotic addicts. Int J Addict 1973; 8:273-292
77. Meyer RE, Mirin SM: The Heroin Stimulus: Implications for a Theory of Addiction. New York, Plenum, 1979
78. O'Brien CP, Childress AR, McLellan AT, Ternes J, Ehrman RN: Use of naltrexone to extinguish opioid-conditioned responses. J Clin Psychiatry 1984; 45:53-56
79. Phillips GT, Gossop M, Bradley B: The influence of psychological factors on the opiate withdrawal syndrome. Br J Psychiatry 1986; 149:235-238
80. Green L, Gossop M: Effects of information on the opiate withdrawal syndrome. Br J Addict 1988; 83:305-309
81. Kramer JC, Fischman VS, Littlefield DC: Amphetamine abuse patterns and effects of high doses taken intravenously. JAMA 1967; 201:305-309
82. Connell PH: Some observations concerning amphetamine misuse: its diagnosis, management and treatment with special reference to research needs, in Drugs and Youth. Edited by Wittenborn JR, Brill H, Smith JP, Wittenborn SA. Springfield, Ill, Charles C Thomas, 1970
83. Watson R, Hartmann E, Schildkraut JJ: Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion. Am J Psychiatry 1972; 129:263-269
84. Ellinwood EH, Petrie WM: Dependence on amphetamine, cocaine and other stimulants, in Drug Abuse: Clinical and Basic Aspects. Edited by Pradhan SN. New York, CV Mosby, 1977
85. Siegel RK: Cocaine smoking. J Psychoactive Drugs 1982; 14:321-337
86. Dackis CA, Gold MS: New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 1985; 147:569-573
87. Gawin FH, Kleber HD: Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: clinical observations. Arch Gen Psychiatry 1986; 43:107-113
88. Brower KJ, Paredes A: Cocaine withdrawal (letter). Arch Gen Psychiatry 1987; 44:297-298
89. Grinspoon L, Balaker JR: Cocaine - A Drug and Its Social Evolution. New York, Basic Books, 1976
90. Weddington WW, Brown BS, Haertzen CA, Cone EJ, Dax EM, Herning RI, Michaelson BS: Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts: a controlled, residential study. Arch Gen Psychiatry 1990; 47:861-868
91. Satel SL, Price LH, Palumbo JM, McDougle CJ, Krystal JH, Gawin F, Charney DS, Heninger GR, Kleber HD: Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am J Psychiatry 1991; 148:1712-1716
92. Washton AM, Gold MS: Chronic cocaine abuse - evidence for adverse effects on health and functioning. Psychiatr Annals 1984; 14:733-739
93. Aronson TA, Craig TJ: Cocaine precipitation of panic disorder. Am J Psychiatry 1986; 143:643-645
94. Louie AK, Lannon RA, Ketter TA: Treatment of cocaine-induced panic disorder. Am J Psychiatry 1989; 146:40-44
95. Geracioti TD, Post RM: Onset of panic disorder associated with rare use of cocaine. Biol Psychiatry 1991; 29:403-406
96. Swann AC: Cocaine: synaptic effects and adaptation, in Cocaine and the Brain. Edited by Volkow ND, Swann AC. New Brunswick, NJ, Rutgers University Press, 1990
97. Gawin FH, Kleber HD: Neuroendocrine findings in chronic cocaine abusers: a preliminary report. Br J Psychiatry 1985; 147:569-573
98. Mendelson JH, Teoh SK, Lange U, Mello NK, Weiss R, Skupny A, Ellingboe J: Anterior pituitary, adrenal, and gonadal hormones during cocaine withdrawal. Am J Psychiatry 1988; 145:1094-1098
99. Martin SD, Yeragani VK, Lodhi R, Galloway MP: Clinical ratings and plasma HVA during cocaine abstinence. Biol Psychiatry 1973; 28:611-616
100. Teoh SK, Mendelson JH, Mello NK, Weiss R, McElroy S, McAfee B: Hyperprolactinemia and risk for relapse of cocaine abuse. Biol Psychiatry 1990; 28:824-828
101. Swartz CM, Breen K, Leone F: Serum prolactin levels during extended cocaine abstinence. Am J Psychiatry 1990; 147:777-779
102. Lee MA, Bowers MM, Nash JF, Meltzer HY: Neurendocrine measures of dopaminergic function in chronic cocaine users. Psychiatry Res 1990; 33:151-159
103. Hollander E, Nunes E, DeCaria C, Quitkin FM, Cooper T, Wager S, Klein DF: Dopaminergic sensitivity in cocaine abuse: response to apomorphine. Psychiatry Res 1990; 33:161-169
104. Kranzler H, Wallington D: Serum prolactin, craving and early discharge from treatment in cocaine-dependent patients. Am J Drug Alcohol Abuse 1992; 18:187-196
105. Oswald I, Thacore VR: Amphetamine and phenmetrazine addiction: physiological abnormalities in the abstinence syndrome. Br Med J 1963; 2:427-431
106. Gossop MR, Bradley BP, Brewis KK: Amphetamine withdrawal and sleep disturbance. Drug Alcohol Depend 1982; 10:177-183
107. Volkow ND, Fowler JS, Wolf AP, Hitzemann R, Dewey S, Bendriem B, Alpert R, Hoff A: Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry 1991; 148:621-626
108. Volkow ND, Fowler JS, Wolf AP, Schlyer D, Shiue C-Y, Alpert R, Dewey SL, Logan J, Bendriem B, Christman D, Hitzemann R, Henn F: Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry 1990; 147:719-724
109. Baxter LR Jr, Schwartz JM, Phelps ME, Mazziotta JC, Barrio J, Rawson RA, Engel J, Guze BH, Selin C, Sumida R: Localization of neurochemical effects of cocaine and other stimulants in the human brain. J Clin Psychiatry 1988; 49(Feb suppl):23-26